HIV-1 induces cytoskeletal alterations and Rac1 activation during monocyte-blood-brain barrier interactions

Modulatory role of CCR5

Shawna M. Woollard, Hong Li, Sangya Singh, Fang Yu, Georgette D Kanmogne

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Most HIV strains that enter the brain are macrophage-tropic and use the CCR5 receptor to bind and infect target cells. Because the cytoskeleton is a network of protein filaments involved in cellular movement and migration, we investigated whether CCR5 and the cytoskeleton are involved in endothelial-mononuclear phagocytes interactions, adhesion, and HIV-1 infection. Results: Using a cytoskeleton phospho-antibody microarray, we showed that after co-culture with human brain microvascular endothelial cells (HBMEC), HIV-1 infected monocytes increased expression and activation of cytoskeleton-associated proteins, including Rac1/cdc42 and cortactin, compared to non-infected monocytes co-cultured with HBMEC. Analysis of brain tissues from HIV-1-infected patients validated these findings, and showed transcriptional upregulation of Rac1 and cortactin, as well as increased activation of Rac1 in brain tissues of HIV-1-infected humans, compared to seronegative individuals and subjects with HIV-1-encephalitis. Confocal imaging showed that brain cells expressing phosphorylated Rac1 were mostly macrophages and blood vessels. CCR5 antagonists TAK-799 and maraviroc prevented HIV-induced upregulation and phosphorylation of cytoskeleton-associated proteins, prevented HIV-1 infection of macrophages, and diminished viral-induced adhesion of monocytes to HBMEC. Ingenuity pathway analysis suggests that during monocyte-endothelial interactions, HIV-1 alters protein expression and phosphorylation associated with integrin signaling, cellular morphology and cell movement, cellular assembly and organization, and post-translational modifications in monocytes. CCR5 antagonists prevented these HIV-1-induced alterations. Conclusions: HIV-1 activates cytoskeletal proteins during monocyte-endothelial interactions and increase transcription and activation of Rac1 in brain tissues. In addition to preventing macrophage infection, CCR5 antagonists could diminish viral-induced alteration and phosphorylation of cytoskeletal proteins, monocyte adhesion to the brain endothelium and viral entry into the central nervous system.

Original languageEnglish (US)
Article number20
JournalRetrovirology
Volume11
Issue number1
DOIs
StatePublished - Feb 26 2014

Fingerprint

Blood-Brain Barrier
HIV-1
Monocytes
Cytoskeleton
Brain
Cortactin
Macrophages
Cytoskeletal Proteins
Endothelial Cells
Phosphorylation
HIV Infections
rac1 GTP-Binding Protein
Up-Regulation
CCR5 Receptors
HIV
Proteins
Encephalitis
Post Translational Protein Processing
Phagocytes
Coculture Techniques

Keywords

  • Cytoskeletal proteins
  • HIV-1
  • Human brain endothelial cells
  • Macrophages
  • Maraviroc
  • Monocytes
  • TAK-779

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

HIV-1 induces cytoskeletal alterations and Rac1 activation during monocyte-blood-brain barrier interactions : Modulatory role of CCR5. / Woollard, Shawna M.; Li, Hong; Singh, Sangya; Yu, Fang; Kanmogne, Georgette D.

In: Retrovirology, Vol. 11, No. 1, 20, 26.02.2014.

Research output: Contribution to journalArticle

@article{8c2192e67a1940dca8797d3e89d35441,
title = "HIV-1 induces cytoskeletal alterations and Rac1 activation during monocyte-blood-brain barrier interactions: Modulatory role of CCR5",
abstract = "Background: Most HIV strains that enter the brain are macrophage-tropic and use the CCR5 receptor to bind and infect target cells. Because the cytoskeleton is a network of protein filaments involved in cellular movement and migration, we investigated whether CCR5 and the cytoskeleton are involved in endothelial-mononuclear phagocytes interactions, adhesion, and HIV-1 infection. Results: Using a cytoskeleton phospho-antibody microarray, we showed that after co-culture with human brain microvascular endothelial cells (HBMEC), HIV-1 infected monocytes increased expression and activation of cytoskeleton-associated proteins, including Rac1/cdc42 and cortactin, compared to non-infected monocytes co-cultured with HBMEC. Analysis of brain tissues from HIV-1-infected patients validated these findings, and showed transcriptional upregulation of Rac1 and cortactin, as well as increased activation of Rac1 in brain tissues of HIV-1-infected humans, compared to seronegative individuals and subjects with HIV-1-encephalitis. Confocal imaging showed that brain cells expressing phosphorylated Rac1 were mostly macrophages and blood vessels. CCR5 antagonists TAK-799 and maraviroc prevented HIV-induced upregulation and phosphorylation of cytoskeleton-associated proteins, prevented HIV-1 infection of macrophages, and diminished viral-induced adhesion of monocytes to HBMEC. Ingenuity pathway analysis suggests that during monocyte-endothelial interactions, HIV-1 alters protein expression and phosphorylation associated with integrin signaling, cellular morphology and cell movement, cellular assembly and organization, and post-translational modifications in monocytes. CCR5 antagonists prevented these HIV-1-induced alterations. Conclusions: HIV-1 activates cytoskeletal proteins during monocyte-endothelial interactions and increase transcription and activation of Rac1 in brain tissues. In addition to preventing macrophage infection, CCR5 antagonists could diminish viral-induced alteration and phosphorylation of cytoskeletal proteins, monocyte adhesion to the brain endothelium and viral entry into the central nervous system.",
keywords = "Cytoskeletal proteins, HIV-1, Human brain endothelial cells, Macrophages, Maraviroc, Monocytes, TAK-779",
author = "Woollard, {Shawna M.} and Hong Li and Sangya Singh and Fang Yu and Kanmogne, {Georgette D}",
year = "2014",
month = "2",
day = "26",
doi = "10.1186/1742-4690-11-20",
language = "English (US)",
volume = "11",
journal = "Retrovirology",
issn = "1742-4690",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - HIV-1 induces cytoskeletal alterations and Rac1 activation during monocyte-blood-brain barrier interactions

T2 - Modulatory role of CCR5

AU - Woollard, Shawna M.

AU - Li, Hong

AU - Singh, Sangya

AU - Yu, Fang

AU - Kanmogne, Georgette D

PY - 2014/2/26

Y1 - 2014/2/26

N2 - Background: Most HIV strains that enter the brain are macrophage-tropic and use the CCR5 receptor to bind and infect target cells. Because the cytoskeleton is a network of protein filaments involved in cellular movement and migration, we investigated whether CCR5 and the cytoskeleton are involved in endothelial-mononuclear phagocytes interactions, adhesion, and HIV-1 infection. Results: Using a cytoskeleton phospho-antibody microarray, we showed that after co-culture with human brain microvascular endothelial cells (HBMEC), HIV-1 infected monocytes increased expression and activation of cytoskeleton-associated proteins, including Rac1/cdc42 and cortactin, compared to non-infected monocytes co-cultured with HBMEC. Analysis of brain tissues from HIV-1-infected patients validated these findings, and showed transcriptional upregulation of Rac1 and cortactin, as well as increased activation of Rac1 in brain tissues of HIV-1-infected humans, compared to seronegative individuals and subjects with HIV-1-encephalitis. Confocal imaging showed that brain cells expressing phosphorylated Rac1 were mostly macrophages and blood vessels. CCR5 antagonists TAK-799 and maraviroc prevented HIV-induced upregulation and phosphorylation of cytoskeleton-associated proteins, prevented HIV-1 infection of macrophages, and diminished viral-induced adhesion of monocytes to HBMEC. Ingenuity pathway analysis suggests that during monocyte-endothelial interactions, HIV-1 alters protein expression and phosphorylation associated with integrin signaling, cellular morphology and cell movement, cellular assembly and organization, and post-translational modifications in monocytes. CCR5 antagonists prevented these HIV-1-induced alterations. Conclusions: HIV-1 activates cytoskeletal proteins during monocyte-endothelial interactions and increase transcription and activation of Rac1 in brain tissues. In addition to preventing macrophage infection, CCR5 antagonists could diminish viral-induced alteration and phosphorylation of cytoskeletal proteins, monocyte adhesion to the brain endothelium and viral entry into the central nervous system.

AB - Background: Most HIV strains that enter the brain are macrophage-tropic and use the CCR5 receptor to bind and infect target cells. Because the cytoskeleton is a network of protein filaments involved in cellular movement and migration, we investigated whether CCR5 and the cytoskeleton are involved in endothelial-mononuclear phagocytes interactions, adhesion, and HIV-1 infection. Results: Using a cytoskeleton phospho-antibody microarray, we showed that after co-culture with human brain microvascular endothelial cells (HBMEC), HIV-1 infected monocytes increased expression and activation of cytoskeleton-associated proteins, including Rac1/cdc42 and cortactin, compared to non-infected monocytes co-cultured with HBMEC. Analysis of brain tissues from HIV-1-infected patients validated these findings, and showed transcriptional upregulation of Rac1 and cortactin, as well as increased activation of Rac1 in brain tissues of HIV-1-infected humans, compared to seronegative individuals and subjects with HIV-1-encephalitis. Confocal imaging showed that brain cells expressing phosphorylated Rac1 were mostly macrophages and blood vessels. CCR5 antagonists TAK-799 and maraviroc prevented HIV-induced upregulation and phosphorylation of cytoskeleton-associated proteins, prevented HIV-1 infection of macrophages, and diminished viral-induced adhesion of monocytes to HBMEC. Ingenuity pathway analysis suggests that during monocyte-endothelial interactions, HIV-1 alters protein expression and phosphorylation associated with integrin signaling, cellular morphology and cell movement, cellular assembly and organization, and post-translational modifications in monocytes. CCR5 antagonists prevented these HIV-1-induced alterations. Conclusions: HIV-1 activates cytoskeletal proteins during monocyte-endothelial interactions and increase transcription and activation of Rac1 in brain tissues. In addition to preventing macrophage infection, CCR5 antagonists could diminish viral-induced alteration and phosphorylation of cytoskeletal proteins, monocyte adhesion to the brain endothelium and viral entry into the central nervous system.

KW - Cytoskeletal proteins

KW - HIV-1

KW - Human brain endothelial cells

KW - Macrophages

KW - Maraviroc

KW - Monocytes

KW - TAK-779

UR - http://www.scopus.com/inward/record.url?scp=84899968245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899968245&partnerID=8YFLogxK

U2 - 10.1186/1742-4690-11-20

DO - 10.1186/1742-4690-11-20

M3 - Article

VL - 11

JO - Retrovirology

JF - Retrovirology

SN - 1742-4690

IS - 1

M1 - 20

ER -